HPN and prostate cancer: Interestingly, Xuan et al. reported that neutralizing antibodies inhibited hepsin’s proteolytic activity in biochemical and cell-based assays and inhibited ovarian and prostate cancer invasion, but the neutralizing antibodies failed to inhibit the growth of prostate, ovarian, and hepatoma cell lines in culture [46].